Tag: mycapssa

  • FDA rejects Chiasma’s drug to treat growth disorder

    (Reuters) – The U.S. Food and Drug Administration has rejected Chiasma Inc’s experimental drug to treat adults with a type of growth disorder, the company said on Friday. Chiasma was evaluating the drug, Mycapssa, in patients with acromegaly, a growth disorder that can result in serious illness and premature death. The Food and Drug Administration…